A Case of Capecitabine-Induced Sarcoidosis.
10.4046/trd.2012.72.3.318
- Author:
Shin Myung KANG
1
;
Ji Yeon BAEK
;
Bin HWANGBO
;
Hyae Young KIM
;
Geon Kook LEE
;
Hee Seok LEE
Author Information
1. Center for Lung Cancer, National Cancer Center, Goyang, Korea. jekyde7@gmail.com
- Publication Type:Case Report
- Keywords:
Sarcoidosis;
Capecitabine;
Sigmoid Neoplasms
- MeSH:
Chemotherapy, Adjuvant;
Deoxycytidine;
Female;
Fluorouracil;
Hematologic Neoplasms;
Hepatitis C, Chronic;
Humans;
Interferon-alpha;
Melanoma;
Ribavirin;
Sarcoidosis;
Sigmoid Neoplasms;
Tumor Necrosis Factor-alpha;
Capecitabine
- From:Tuberculosis and Respiratory Diseases
2012;72(3):318-322
- CountryRepublic of Korea
- Language:English
-
Abstract:
Sarcoidosis is an inflammatory disease involving multiple-organs with an unknown cause. The new onset of sarcoidosis associated with therapeutic agents has been observed in 3 clinical settings; tumor necrosis factor antagonists in autoimmune rheumatologic diseases, interferon alpha with or without ribavirin in patients with chronic hepatitis C or melanoma, and antineoplastic agent-associated sarcoidosis in patients with hematologic malignancies. Here, we report a female patient who developed sarcoidosis after capecitabine treatment as an adjuvant chemotherapy for sigmoid colon cancer. To our knowledge, this is the first report of a capecitabine-induced sarcoidosis.
